Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Imuldosa™ (ustekinumab-srlf) – New biosimilar approval

October 10, 2024 - Accord announced the FDA approval of Imuldosa (ustekinumab-srlf), biosimilar to Janssen’s Stelara® (ustekinumab).

Download PDF

Rx navigation